Filing Details
- Accession Number:
- 0001567619-20-017589
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-10-05 17:31:44
- Reporting Period:
- 2020-10-01
- Accepted Time:
- 2020-10-05 17:31:44
- Original Submission Date:
- 2020-10-05
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1533743 | Processa Pharmaceuticals Inc. | PCSA | Pharmaceutical Preparations (2834) | 451539785 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1799363 | Patrick Lin | C/O Processa Pharmaceuticals, Inc. 7380 Coca Cola Drive, Suite 106 Hanover MD 21076 | Chief Business - Strategy Off | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-10-01 | 31,250 | $4.00 | 399,737 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This amended Form 4 is being filed to correct the purchase price for the reported transaction.